Quality and Efficacy Concerns with Generics in Treatment of Hepatitis C with Directly Acting Antivirals
Treating hepatitis C has never been so convenient after the advent of Directly Acting Antivirals (DAA). Convenience is at both ends; for the doctors to prescribe and for patients to comply due to all oral therapy with few adverse effects. Many are already in market, these include, Sofosbuvir, Decla...
Main Author: | Bader Faiyaz Zuberi |
---|---|
Format: | Article |
Language: | English |
Published: |
Dow University of Health Sciences
2017-08-01
|
Series: | Journal of the Dow University of Health Sciences |
Online Access: | https://jduhs.com/index.php/jduhs/article/view/1381 |
Similar Items
-
Quality and Efficacy Concerns with Generics in Treatment of Hepatitis C with Directly Acting Antivirals
by: Bader Faiyaz Zuberi
Published: (2017-08-01) -
HEPATITIS D: A REVIEW
by: Bader Faiyaz Zuberi
Published: (2007-04-01) -
HEPATITIS D: A REVIEW
by: Bader Faiyaz Zuberi
Published: (2007-04-01) -
Pangenotypic Direct Acting Antivirals Treatment for Chronic Hepatitis C Infection
by: Juferdy Kurniawan
Published: (2020-07-01) -
Characterisation of Hepatitis C Virus antiviral resistance in the era of direct acting antivirals
by: Smith, D
Published: (2019)